Zinzino AB (publ) reported preliminary sales results for the month and year to date ended February 2023. For the month, the company reported revenue for Zinzino's sales markets increased by 23% and amounted to SEK 109.6 (89.0) million. Faun Pharma's external sales increased by 34% and amounted to SEK 8.7 (6.5) million. Overall, the Group increased revenues by 24% to SEK 118.3 (95.5) million compared with the previous year.

For the year to date, the company reported revenue for Zinzino's sales markets increased by 20% and amounted to SEK 229.9 (191.1) million. Faun Pharma's external sales increased by 33% and amounted to SEK 17.8 (13.4) million. Overall, the Group increased revenues by 21% to SEK 247.7 (204.5) million compared with the previous year.